Pharmacogenetics and pharmacogenomics of anticancer agents.
about
Pharmacogenomics discovery and implementation in genome-wide association studies eraCost-Effectiveness of Pharmacogenomic and Pharmacogenetic Test-Guided Personalized Therapies: A Systematic Review of the Approved Active Substances for Personalized Medicine in GermanyAnalysing the Effect of Mutation on Protein Function and Discovering Potential Inhibitors of CDK4: Molecular Modelling and Dynamics StudiesThe evolving discipline of molecular epidemiology of cancer.Genotype, allele and haplotype frequencies of four TCL1A gene polymorphisms associated with musculoskeletal toxicity in the South Indian descent.Genetic factors affecting gene transcription and catalytic activity of UDP-glucuronosyltransferases in human liverIdentification of a variant in KDR associated with serum VEGFR2 and pharmacodynamics of PazopanibGenetic variation predicting cisplatin cytotoxicity associated with overall survival in lung cancer patients receiving platinum-based chemotherapy.Copy number polymorphisms and anticancer pharmacogenomicsThe cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markers.Personalized therapy in endometrial cancer: challenges and opportunities.Chemotherapy-induced neutropenia during adjuvant treatment for cervical cancer patients: development and validation of a prediction model.THRB genetic polymorphisms can predict severe myelotoxicity after definitive chemoradiotherapy in patients with esophageal squamous cell carcinoma.Genetic screening reveals a link between Wnt signaling and antitubulin drugs.Pharmacogenetics in breast cancer: steps toward personalized medicine in breast cancer managementThe role of pharmacoethnicity in the development of cytotoxic and molecular targeted drugs in oncologyPharmacogenetics and pharmacogenomics: a bridge to individualized cancer therapy.Cancer pharmacoethnicity: ethnic differences in susceptibility to the effects of chemotherapy.A phase II study of preoperative chemoradiation with tegafur-uracil plus leucovorin for locally advanced rectal cancer with pharmacogenetic analysisMolecular diagnostics for pharmacogenomic testing of fluoropyrimidine based-therapy: costs, methods and applications.Tumor markers in clinical practice: a review focusing on common solid cancersMolecular diagnostic strategies: a role in the practice of dermatology.Insights on practice variations in the management of lymphoma and leukemia.Pharmacogenetics of cancer therapy: breakthroughs from beyond?Non-coding RNAs Enabling Prognostic Stratification and Prediction of Therapeutic Response in Colorectal Cancer Patients.Pharmacogenetics and Pharmacogenomics of Targeted Therapeutics in Chronic Myeloid Leukemia.Natural resistance to apoptosis correlates with resistance to chemotherapy in colorectal cancer cells.Plant phytochemicals as new potential drugs for immune disorders and cancer therapy: really a promising path?A pharmacogenetic study of vorinostat glucuronidation.Translating pharmacogenomics discoveries into the clinic: an implementation framework.A pharmacogene database enhanced by the 1000 Genomes Project.Pharmacogenetic analysis in neoadjuvant chemoradiation for rectal cancer: high incidence of somatic mutations and their relation with response.Genome-wide association study of myelosuppression in non-small-cell lung cancer patients with platinum-based chemotherapy.Intravital biobank and personalized cancer therapy: the correlation with omics.DPYD*2A and MTHFR C677T predict toxicity and efficacy, respectively, in patients on chemotherapy with 5-fluorouracil for colorectal cancer.Fatal adverse drug reactions of anticancer drugs detected by all-case post-marketing surveillance in Japan.Pharmacogenomics testing in a community pharmacy: patient perceptions and willingness-to-pay.Pharmacogenetic studies with oral anticoagulants. Genome-wide association studies in vitamin K antagonist and direct oral anticoagulants.Massively Parallel Sequencing
P2860
Q27001573-21212B34-86BA-4C0F-BD02-8C2947FBF84DQ28072203-1ED467EC-5E48-4BFD-A57F-F0421E468DD6Q28547120-F286E2DF-68C1-4BBE-9FCB-F5C10F342B59Q33575696-3D2451E8-59EA-4CBE-850F-6E02CD446414Q33901118-01453C9E-3EF8-403A-BBDB-D7F38696B8D9Q34211851-4877F9B1-0CFA-4343-9FFD-56E4956057E7Q35068932-B316F008-94CC-4F8C-8C1D-E6D0E0CF90F4Q35196480-E3FFF894-2D92-4CFF-8B42-72D3FC139AD0Q35561161-AA85AB60-CFC8-404D-BFB2-7363CF883023Q35832370-0EA56353-1014-4EB8-B067-97B0297B2628Q35911350-1CD5E0B0-224C-4356-8DAE-5A1CEBBFB2B6Q36046284-1C27DF8A-7B1F-43B1-9A7F-DC2A7F3890CEQ36378181-3665AA29-9680-417E-9E8F-BEAE9683F72EQ36441268-CE9A5DE3-4FE3-4CBA-9A10-6B297770F26EQ36441485-B50C3FB5-C066-4012-A5FF-5588153A9F2BQ36463971-4E745269-78E0-46CF-8F0D-6329BC6C6CF6Q36709301-E8BD5B4E-F286-4CD5-8461-6DA8779D5BAEQ37414536-7ECD5C08-E0F9-4CCB-AF5B-8E2E4498AD82Q37724706-6C99C163-E65B-4328-A55C-4A88AAB9D3E7Q37866805-3F116B93-98C5-4DC5-ABD7-E04C62B5BBEBQ38010046-ED0A5118-A70F-4FD2-94DB-9ECC719CE352Q38052162-9E27F39B-B42F-4572-9D64-31ACB43E1046Q38177354-C55A3CE2-706D-42FC-BE76-643A2C54A3D3Q38776883-F7C42795-03BE-41DA-BBAD-F2A8B25CF1D7Q38826546-4AD949AD-5183-4CD2-9B5E-0AB5507D6C39Q39429836-92972209-6E99-4A5D-AEF4-F0429FE00E9BQ39521576-61753170-6143-4E96-8970-BCB7024F8DAEQ39633051-7F01B346-5720-4831-A1F0-47FC733C4FE3Q40121072-615B242C-6047-4D2D-9A17-5C95ACC65431Q40996398-04B92862-355D-469B-8F81-CEBAD199C4B3Q41868712-DA26B47C-0DBE-4C7C-B487-F94091054A1BQ43053804-00A1CB2B-02E1-41D1-A9F0-657B00B00038Q47425743-BEF004FD-BC23-4051-BFB1-0E741AFC4504Q47825939-A1B14F3F-BD03-4BFC-9902-A52DC0C231EAQ48310481-291AF95A-E193-4064-A4B7-5504814783CFQ50949890-DECB85C6-E861-457B-B5AA-9125C0912856Q53672069-038AD5FD-A30F-4C4B-8EE5-F868B43ED932Q55717925-EDA22A45-2BA6-4682-8779-BD7F6B3C32CDQ57386650-B99AB630-7EDB-4580-885E-B7AEAA805913
P2860
Pharmacogenetics and pharmacogenomics of anticancer agents.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Pharmacogenetics and pharmacogenomics of anticancer agents.
@ast
Pharmacogenetics and pharmacogenomics of anticancer agents.
@en
type
label
Pharmacogenetics and pharmacogenomics of anticancer agents.
@ast
Pharmacogenetics and pharmacogenomics of anticancer agents.
@en
prefLabel
Pharmacogenetics and pharmacogenomics of anticancer agents.
@ast
Pharmacogenetics and pharmacogenomics of anticancer agents.
@en
P2860
P356
P1433
P1476
Pharmacogenetics and pharmacogenomics of anticancer agents
@en
P2860
P356
10.3322/CAAC.20002
P407
P577
2009-01-01T00:00:00Z